Common use of Initial Press Releases Clause in Contracts

Initial Press Releases. Upon the execution of this Agreement, the Parties shall issue mutually agreed press releases regarding the subject matter of this Agreement, including a description of the aggregate financial terms and value of the Agreement, in the forms attached hereto as Schedule 14.3.2.

Appears in 1 contract

Sources: Collaboration and License Agreement (Gossamer Bio, Inc.)

Initial Press Releases. Upon Promptly following the execution of this AgreementEffective Date, the Parties shall will issue a mutually agreed upon press releases release regarding the subject matter of this Agreement, including a description of the aggregate financial terms terms, a high-level description of the overall scope of the transaction and the scope of planned Development and value of the Agreement, Agreement in the forms form attached hereto as Schedule 14.3.2.Exhibit B.

Appears in 1 contract

Sources: Collaboration and License Agreement (Aveo Pharmaceuticals Inc)

Initial Press Releases. Upon Promptly following the execution of this AgreementEffective Date, the Parties shall will issue a mutually agreed upon press releases release regarding the subject matter of this Agreement, including a description of the aggregate financial terms terms, a high-level description of the overall scope of the transaction and the scope of planned Development and value of the Agreement, Agreement in the forms form attached hereto as Schedule 14.3.28.2.1.

Appears in 1 contract

Sources: Collaboration and License Agreement (Puma Biotechnology, Inc.)

Initial Press Releases. Upon Promptly following the execution of this AgreementExecution Date, the Parties shall issue a mutually agreed press releases release regarding the subject matter of this Agreement, including a description of the aggregate financial terms terms, scope of planned Development and value of the Agreement, in the forms form attached hereto as Schedule 14.3.2.Exhibit E.

Appears in 1 contract

Sources: Collaboration and License Agreement (Infinity Pharmaceuticals, Inc.)